Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00395-011-0192-x.

Title:
Necrotic cell death in atherosclerosis | Basic Research in Cardiology
Description:
Necrosis is a type of cell death characterized by a gain in cell volume, swelling of organelles, rupture of the plasma membrane and subsequent loss of intracellular contents. For a long time, the process has been considered as a merely accidental and uncontrolled form of cell death, but accumulating evidence suggests that it can also occur in a regulated fashion. Morphological studies using transmission electron microscopy indicate that the vast majority of dying cells in advanced human atherosclerotic plaques undergo necrosis. Various stimuli in the plaque including high levels of oxidative stress, depletion of cellular ATP, impaired clearance of apoptotic cells and increased intracellular calcium may cause necrotic death. Although the role of necrosis in atherosclerosis remains ill-defined, a growing body of evidence suggests that necrotic death stimulates atherogenesis through induction of inflammation and enlargement of the necrotic core. In addition, necrosis contributes to plaque instability by releasing tissue factor, matrix degrading proteases and pro-angiogenic compounds. Therapeutic agents against necrosis are limited, but efforts have recently been made to inhibit the necrotic pathway or its pro-inflammatory effects.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Education
  • Telecommunications
  • Health & Fitness

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We're unsure how the site profits.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {πŸ”}

google, scholar, pubmed, cas, cell, atherosclerosis, death, cells, atherosclerotic, biol, necrosis, apoptosis, plaque, human, mice, res, cardiol, basic, apoptotic, thromb, dois, article, necrotic, arterioscler, vasc, macrophages, lesions, protein, tabas, endothelial, doi, vascular, van, martinet, meyer, oxidative, role, effects, circulation, hmgb, advanced, plaques, chem, expression, cyclophilin, macrophage, schrijvers, stress, inflammation, factor,

Topics {βœ’οΈ}

val-gly-val-ala-pro-gly tlr4/nf-kappab signaling pathway anti-tnf-alpha inhibitors high mobility group tnf-alpha blockade play collagen peptide-induced chemotaxis multi-slice computed tomography pro-inflammatory activities induced month download article/chapter intima-media thickness evolution inflammatory immune-mediated diseases atherosclerosis remains ill-defined apolipoprotein e-deficient mice ovariectomized apoe-deficient mice independent prognostic factor vivo improves number rupture-prone plaque phenotype dna-binding cytokine hmgb1 dyslipidemia-induced autonomic article basic research protein synthesis persists smooth muscle cells beta2-integrin activation privacy choices/manage cookies apoptotic cell accumulation diet-induced atherosclerosis human atherosclerotic plaques releasing tissue factor hyaluronan fragments act inhibits phosphatidylserine externalization scientific research-flanders necrotic cell death pro-angiogenic compounds chromatin protein hmgb1 mediates vascular remodeling advanced atherosclerotic lesions cell death characterized nonapoptotic cell death foam cell death full article pdf human endothelial cells van de ven related subjects specific cellular target lipid-rich core activates endothelial cells bcl-2 alters endothelial progenitor cells improved endothelial function van tits lj

Questions {❓}

  • Cuchacovich R, Espinoza LR (2009) Does TNF-alpha blockade play any role in cardiovascular risk among rheumatoid arthritis (RA) patients?
  • Kockx MM, Herman AG (2000) Apoptosis in atherosclerosis: beneficial or detrimental?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Necrotic cell death in atherosclerosis
         description:Necrosis is a type of cell death characterized by a gain in cell volume, swelling of organelles, rupture of the plasma membrane and subsequent loss of intracellular contents. For a long time, the process has been considered as a merely accidental and uncontrolled form of cell death, but accumulating evidence suggests that it can also occur in a regulated fashion. Morphological studies using transmission electron microscopy indicate that the vast majority of dying cells in advanced human atherosclerotic plaques undergo necrosis. Various stimuli in the plaque including high levels of oxidative stress, depletion of cellular ATP, impaired clearance of apoptotic cells and increased intracellular calcium may cause necrotic death. Although the role of necrosis in atherosclerosis remains ill-defined, a growing body of evidence suggests that necrotic death stimulates atherogenesis through induction of inflammation and enlargement of the necrotic core. In addition, necrosis contributes to plaque instability by releasing tissue factor, matrix degrading proteases and pro-angiogenic compounds. Therapeutic agents against necrosis are limited, but efforts have recently been made to inhibit the necrotic pathway or its pro-inflammatory effects.
         datePublished:2011-05-25T00:00:00Z
         dateModified:2011-05-25T00:00:00Z
         pageStart:749
         pageEnd:760
         sameAs:https://doi.org/10.1007/s00395-011-0192-x
         keywords:
            Cell death
            Necrosis
            Apoptosis
            Necrotic core
            Atherosclerosis
            Cardiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-011-0192-x/MediaObjects/395_2011_192_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-011-0192-x/MediaObjects/395_2011_192_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-011-0192-x/MediaObjects/395_2011_192_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-011-0192-x/MediaObjects/395_2011_192_Fig4_HTML.gif
         isPartOf:
            name:Basic Research in Cardiology
            issn:
               1435-1803
               0300-8428
            volumeNumber:106
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Wim Martinet
               affiliation:
                     name:University of Antwerp
                     address:
                        name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Dorien M. Schrijvers
               affiliation:
                     name:University of Antwerp
                     address:
                        name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Guido R. Y. De Meyer
               affiliation:
                     name:University of Antwerp
                     address:
                        name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Necrotic cell death in atherosclerosis
      description:Necrosis is a type of cell death characterized by a gain in cell volume, swelling of organelles, rupture of the plasma membrane and subsequent loss of intracellular contents. For a long time, the process has been considered as a merely accidental and uncontrolled form of cell death, but accumulating evidence suggests that it can also occur in a regulated fashion. Morphological studies using transmission electron microscopy indicate that the vast majority of dying cells in advanced human atherosclerotic plaques undergo necrosis. Various stimuli in the plaque including high levels of oxidative stress, depletion of cellular ATP, impaired clearance of apoptotic cells and increased intracellular calcium may cause necrotic death. Although the role of necrosis in atherosclerosis remains ill-defined, a growing body of evidence suggests that necrotic death stimulates atherogenesis through induction of inflammation and enlargement of the necrotic core. In addition, necrosis contributes to plaque instability by releasing tissue factor, matrix degrading proteases and pro-angiogenic compounds. Therapeutic agents against necrosis are limited, but efforts have recently been made to inhibit the necrotic pathway or its pro-inflammatory effects.
      datePublished:2011-05-25T00:00:00Z
      dateModified:2011-05-25T00:00:00Z
      pageStart:749
      pageEnd:760
      sameAs:https://doi.org/10.1007/s00395-011-0192-x
      keywords:
         Cell death
         Necrosis
         Apoptosis
         Necrotic core
         Atherosclerosis
         Cardiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-011-0192-x/MediaObjects/395_2011_192_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-011-0192-x/MediaObjects/395_2011_192_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-011-0192-x/MediaObjects/395_2011_192_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00395-011-0192-x/MediaObjects/395_2011_192_Fig4_HTML.gif
      isPartOf:
         name:Basic Research in Cardiology
         issn:
            1435-1803
            0300-8428
         volumeNumber:106
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Wim Martinet
            affiliation:
                  name:University of Antwerp
                  address:
                     name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Dorien M. Schrijvers
            affiliation:
                  name:University of Antwerp
                  address:
                     name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Guido R. Y. De Meyer
            affiliation:
                  name:University of Antwerp
                  address:
                     name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Basic Research in Cardiology
      issn:
         1435-1803
         0300-8428
      volumeNumber:106
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Antwerp
      address:
         name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
         type:PostalAddress
      name:University of Antwerp
      address:
         name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
         type:PostalAddress
      name:University of Antwerp
      address:
         name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Wim Martinet
      affiliation:
            name:University of Antwerp
            address:
               name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Dorien M. Schrijvers
      affiliation:
            name:University of Antwerp
            address:
               name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
               type:PostalAddress
            type:Organization
      name:Guido R. Y. De Meyer
      affiliation:
            name:University of Antwerp
            address:
               name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
      name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
      name:Division of Pharmacology, University of Antwerp, Antwerp, Belgium
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(322)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.53s.